{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:11:00Z","timestamp":1778778660135,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 108-S4228"],"award-info":[{"award-number":["NTUH 108-S4228"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jfma.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T03:54:19Z","timestamp":1600833259000},"page":"1114-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Factors to influence the accuracy of albumin adjusted free valproic acid concentration"],"prefix":"10.1016","volume":"120","author":[{"given":"Yu-Ju","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsuan","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.09.004_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jfma.2020.09.004_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jfma.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1176\/ajp.2006.163.11.1891","article-title":"An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions","volume":"163","author":"Sandson","year":"2006","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jfma.2020.09.004_bib4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia","volume":"37","author":"Dore","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jfma.2020.09.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"5","author":"Gugler","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jfma.2020.09.004_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00007691-197901000-00011","article-title":"Valproic acid: in\u00a0vitro plasma protein binding and interaction with phenytoin","volume":"1","author":"Cramer","year":"1979","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jfma.2020.09.004_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/FTD.0000000000000316","article-title":"The effect of different carbapenem antibiotics (Ertapenem, imipenem\/cilastatin, and meropenem) on serum valproic acid concentrations","volume":"38","author":"Wu","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jfma.2020.09.004_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jfma.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00007691-198004000-00015","article-title":"Monitoring of free valproic acid levels?","volume":"2","author":"Levy","year":"1980","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jfma.2020.09.004_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(85)90082-8","article-title":"Free drug measurements: methodology and clinical significance","volume":"151","author":"Kwong","year":"1985","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jfma.2020.09.004_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/CCLM.2002.172","article-title":"Clinical utility of free drug monitoring","volume":"40","author":"Dasgupta","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jfma.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1254\/jphs.FPE04007X","article-title":"A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients","volume":"97","author":"Hermida","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jfma.2020.09.004_bib13","first-page":"649","article-title":"[Valproic acid: a simple method for the estimation of free serum concentration]","volume":"51","author":"Parent","year":"1993","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.jfma.2020.09.004_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","author":"Drisaldi","year":"2019","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jfma.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/phar.1912","article-title":"Valproate protein binding is highly variable in ICU patients and not predicted by total serum concentrations: a case series and literature review","volume":"37","author":"Riker","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jfma.2020.09.004_bib16","series-title":"Basic clinical pharmacokinetics","author":"Winter","year":"2010"},{"key":"10.1016\/j.jfma.2020.09.004_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1528-1157.1989.tb05478.x","article-title":"Serum bilirubin levels with antiepileptic drugs","volume":"30","author":"Gough","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.jfma.2020.09.004_bib18","first-page":"201","article-title":"Displacement effect of valproate on bilirubin-albumin binding in human plasma","volume":"98","author":"Yu","year":"1999","journal-title":"J Formosan Med Assoc Taiwan yi zhi"},{"key":"10.1016\/j.jfma.2020.09.004_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620304277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620304277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:23:38Z","timestamp":1778775818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620304277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0929664620304277"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.09.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors to influence the accuracy of albumin adjusted free valproic acid concentration","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}